Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Intrauterine copper contraceptive implants]

H Van Kets1, M Thiery, D Wildemeersch

  • 1Service de Gynécologie et d'Obstétrie, Hôpital Universitaire de Gand, Belgique.

Contraception, Fertilite, Sexualite (1992)
|December 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Survival of cervical cancer patients at Moi teaching and Referral Hospital, Eldoret in western Kenya.

BMC cancer·2023
Same author

Treatment of women with BRCA mutation.

Climacteric : the journal of the International Menopause Society·2023
Same author

Determinants of preconception care among pregnant women in an urban and a rural health facility in Kenya: a qualitative study.

BMC pregnancy and childbirth·2021
Same author

Routine third-trimester ultrasound for the detection of small-for-gestational age in low-risk pregnancies (ROTTUS study): randomized controlled trial.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2021
Same author

A randomized trial on the effect of oral combined estradiol and drospirenone on glucose and insulin metabolism in healthy menopausal women with a normal oral glucose tolerance test.

Maturitas·2020
Same author

Delivery mode for prolonged, obstructed labour resulting in obstetric fistula: a retrospective review of 4396 women in East and Central Africa.

BJOG : an international journal of obstetrics and gynaecology·2019
Same journal

[Inflammatory and/or locally advanced breast cancers. Difficulty evaluating the response to initial chemotherapy].

Contraception, fertilite, sexualite (1992)·2000
Same journal

[Proximal tubal unblocking by selective salpingography, apropos of 8 cases].

Contraception, fertilite, sexualite (1992)·2000
Same journal

[Anatomoclinical correlations of endometriosis].

Contraception, fertilite, sexualite (1992)·2000
Same journal

[Effects of raloxifene on bone loss and fracture risk in the menopausal woman].

Contraception, fertilite, sexualite (1992)·2000
Same journal

[Cytological screening of uterine cervical cancer by samples in liquid medium (CytoRich). Preliminary study of a series of 111 292 patients].

Contraception, fertilite, sexualite (1992)·2000
Same journal

[Diabetes before pregnancy, apropos of 143 cases].

Contraception, fertilite, sexualite (1992)·2000
See all related articles

GyneFix, a frameless intrauterine device (IUD), offers high effectiveness and optimal tolerance by minimizing expulsion, bleeding, and pain. Its unique design makes it a safe and reversible contraceptive option for women, including nulliparous individuals.

Area of Science:

  • Reproductive Health
  • Contraception
  • Gynecology

Context:

  • Intrauterine devices (IUDs) are a common form of reversible contraception.
  • Conventional IUDs can be associated with issues like expulsion, bleeding, and pain, leading to discontinuation.
  • The GyneFix IUD was developed to address these limitations.

Purpose:

  • To evaluate the safety, effectiveness, and user acceptance of the GyneFix IUD.
  • To assess the GyneFix IUD's performance in a large cohort, including nulliparous women.
  • To compare GyneFix IUD outcomes with other contraceptive methods.

Summary:

  • The frameless, flexible GyneFix IUD, fixed to the uterine fundus, demonstrates optimal tolerance and minimal expulsion rates.
  • Clinical trials with over 10,000 woman-years of follow-up show GyneFix is highly effective, comparable to oral contraceptives and sterilization.

Related Experiment Videos

  • Its design avoids frame-related uterine incompatibility, potentially explaining the absence of pelvic inflammatory disease and ectopic pregnancies in studies.

    • Impact:

    • GyneFix offers enhanced contraceptive effectiveness and high continuation rates, serving as a reversible alternative to oral contraceptives and surgical sterilization.
    • The device is easily inserted and removed, with a painless procedure.
    • GyneFix is a well-accepted and effective contraceptive method for nulliparous women.